Clinical Trial Update: Immunomodulation With Romiplostim in Young Adults With ITP [Phase 4]

View source ↗

Summary

Phase 4 trial update on immunomodulation with romiplostim in young adults with immune thrombocytopenia has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• Romiplostim (romiplostim)

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Immune Thrombocytopenia | Phase 4 | Status: COMPLETED